Regencell Bioscience Holdings Limited (RGC) Added to S&P Global BMI Index Amid Positive ADHD/ASD Trial Results [Yahoo! Finance]
Regencell Bioscience Holdings Limited - Ordinary Shares (RGC)
Last regencell bioscience holdings limited - ordinary shares earnings: 10/24 04:10 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.regmovies.com
Company Research
Source: Yahoo! Finance
Regencell Bioscience Holdings Limited (NASDAQ:RGC) tops our list for being one of the stocks with insider buying . It is a Hong Kong-based biopharmaceutical company developing Traditional Chinese Medicine (TCM) treatments for neurocognitive disorders such as ADHD and autism spectrum disorder (ASD). A key milestone came on September 21, 2025, when RGC was added to the S&P Global BMI Index, boosting its visibility among institutional and passive investors. This inclusion may enhance liquidity and help stabilize the stock, which has been highly volatile. Despite this progress, the business continues to face fundamental challenges, including zero revenue, ongoing losses, and uncertain regulatory pathways for its treatments. On the clinical front, Regencell Bioscience Holdings Limited (NASDAQ:RGC) reported positive results from its second efficacy trial using standardized TCM formulae for ADHD and ASD, showing a mean symptom improvement of 37% with no adverse side effects. While encou
Show less
Read more
Impact Snapshot
Event Time:
RGC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGC alerts
High impacting Regencell Bioscience Holdings Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RGC
News
- Regencell Bioscience: Material Weaknesses Add To Woes [Seeking Alpha]Seeking Alpha
- Bragar Eagel & Squire, P.C. Continues Investigations into Regencell, Beyond Meat, Alvotech, and Camping World on Behalf of Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regencell Bioscience Holdings Limited - RGCPR Newswire
- Regencell Bioscience (NASDAQ:RGC) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Bragar Eagel & Squire, P.C. Is Investigating Regencell, Beyond Meat, Alvotech, and Camping World and Encourages Investors to Contact the FirmGlobeNewswire